- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
Patent holdings for IPC class C07K 14/34
Total number of patents in this class: 449
10-year publication summary
31
|
23
|
37
|
52
|
37
|
36
|
63
|
38
|
45
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
CJ Cheiljedang Corporation | 3256 |
114 |
Ajinomoto Co., Inc. | 2319 |
20 |
Glaxosmithkline Biologicals S.A. | 1696 |
16 |
Pfizer Inc. | 3368 |
9 |
Ningxia Eppen Biotech Co., Ltd | 26 |
9 |
Evonik Operations GmbH | 4021 |
9 |
Daesang Corporation | 301 |
8 |
Scarab Genomics, LLC | 42 |
7 |
Merck Sharp & Dohme LLC | 3751 |
7 |
Fina BioSolutions, LLC | 18 |
6 |
Scott & White Memorial Hospital | 9 |
6 |
Wake Forest University Health Sciences | 717 |
6 |
Biological e Limited | 67 |
6 |
Wyeth LLC | 671 |
5 |
The Governors of the University of Alberta | 884 |
5 |
Korea University Research and Business Foundation | 2809 |
5 |
National Research Council of Canada | 1569 |
5 |
The Scripps Research Institute | 1353 |
5 |
Jiangnan University | 1480 |
4 |
The Regents of the University of Colorado, a body corporate | 2530 |
4 |
Other owners | 193 |